- Datasheet
- References (6)
- Inventor Info
Info
| Catalogue Number | 153873 |
| Antigen/Gene or Protein Targets | Ovarian cancer |
| Parental Line | primary ovarian carcinoma |
| Host | Human |
| Tissue | Ovary |
| Disease Keywords | Ovarian carcinoma |
| Model | Cancer Model |
| Relevance | BG-1 is a human ovarian carcinoma cell line that has functional and clinically relevent estrogen receptors and progesterone receptors. |
| Research Area | Cancer |
References: 6 entries
Baldwin et al. 1998. In Vitro Cell Dev Biol Anim. 34(8):649-54. PMID: 9769151.
BG-1 ovarian cell line: an alternative model for examining estrogen-dependent growth in vitro.
Europe PMC ID: 9769151
Pavlik et al. 1991. Gynecol Oncol. 42(3):245-9. PMID: 1955187.
The growth response of BG-1 ovarian carcinoma cells to estradiol, 4OH-tamoxifen, and tamoxifen: evidence for intrinsic antiestrogen activation.
Europe PMC ID: 1955187
Geisinger et al. 1989. Cancer. 63(2):280-8. PMID: 2910432.
Characterization of a human ovarian carcinoma cell line with estrogen and progesterone receptors.
Europe PMC ID: 2910432
Add a reference
References: 6 entries
Baldwin et al. 1998. In Vitro Cell Dev Biol Anim. 34(8):649-54. PMID: 9769151.
BG-1 ovarian cell line: an alternative model for examining estrogen-dependent growth in vitro.
Pavlik et al. 1991. Gynecol Oncol. 42(3):245-9. PMID: 1955187.
The growth response of BG-1 ovarian carcinoma cells to estradiol, 4OH-tamoxifen, and tamoxifen: evidence for intrinsic antiestrogen activation.
Geisinger et al. 1989. Cancer. 63(2):280-8. PMID: 2910432.
Characterization of a human ovarian carcinoma cell line with estrogen and progesterone receptors.
Add a reference
Inventor Information
Inventors
|
Michael E. Berens, Ph.D. |
